Steward Partners Investment Advisory »

Acrivon Therapeutics shares owned by Steward Partners Investment Advisory

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Steward Partners Investment Advisory from 13F filings

Historical chart of Steward Partners Investment Advisory investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Steward Partners Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Steward Partners Investment Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $453 326 1.39

More positions owned by Steward Partners Investment Advisory

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Core Msci Emkt (IEMG)
JPMorgan Chase & Co. (JPM)
Spdr Gold Tr Gold Shs (GLD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Steward Partners Investment Advisory

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Wellington Management Company
Acadian Asset Management
Renaissance Technologies
Vanguard Capital Management
Vanguard Group
Marshall Wace
Two Sigma Investments
Jane Street
Geode Capital Management
BlackRock
GSA Capital Partners
Bridgeway Capital Management
Vanguard Fiduciary Trust

View all funds holding Acrivon Therapeutics